This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

South Korea creates ultra-fast IP review program for AI, biotech startups

( February 23, 2026, 06:05 GMT | Official Statement) -- MLex Summary: South Korea’s Ministry of Intellectual Property on Monday created an ultra-fast-track review program for intellectual property applications submitted by startup companies in the fields of artificial intelligence and advanced biotechnology. Under the program, up to 2,000 ultra-fast examinations will be provided per year in each of the two technology fields. The ministry expects the new program to significantly shorten the examination waiting period for AI and biotech startup applications, helping startups secure rights more quickly and bolstering the startup boom. Applicants will now be able to receive a first examination result within one month under the ultra-fast track or within two months under the expedited track, compared with an average of 14.7 months for ordinary examinations, the ministry added.Statement is attached (in Korean)....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login